World Contraception Day is an annual campaign on September 26, supported by 17 nongovernmental organizations (NGOs), “around a vision where every pregnancy is wanted.” In the words of the World Health Organization, World Contraception Day’s mission is “to improve awareness of all contraceptive methods available and enable young people to make informed choices on their sexual and reproductive health.”
Health Decisions considers World Contraception Day an occasion to celebrate the availability of a wide range of contraceptive options while also recognizing that there is still room for improvement. Developers are continuing to fuel innovation as shown in a variety of recent and current Health Decisions clinical trials of novel contraceptives. Another example of continuing innovation is the recent FDA approval of a smartphone app that women can use to determine days on which they are unlikely to become pregnant if they have unprotected sex. In typical use, studies have demonstrated that women using the app have a 7.5% probability of becoming pregnant. The probability of pregnancy is substantially lower with perfect use. However, both clinical trials and real-world experience show that perfect use is far from universal with contraceptives that require intervention before intercourse.
Many Types of Contraceptives Are Available But Women Are Still Seeking Alternatives
The FDA’s recent approval of the contraceptive app provides evidence that women, like developers, are still searching for new contraceptive options that better meet their needs. Data showing that women change contraceptive methods frequently provides further evidence on this point. The Health Decisions clinical development team understands the advantages and disadvantages of existing contraceptives based on conducting 39 studies evaluating virtually all types of contraceptive drugs, devices and drug/device combinations. This includes oral contraceptives, intrauterine devices and systems, vaginal rings, transdermal patches, injections, gels, creams and barrier devices.
Health Decisions has evaluated contraceptives for long-term use, including oral contraceptives and the increasingly important category of long-acting reversible contraceptives (LARCs) like intrauterine devices and systems. We have also conducted studies of contraceptives for episodic use, such as male and female condoms and hormonal emergency contraceptives. Health Decisions’ experience with contraceptive studies even includes 10 studies of investigational male hormonal contraceptives. These have the game-changing potential to expand the range of contraceptive options both for sexually active men and for women in stable relationships. We are confident that future World Contraception Days will celebrate an expanded range of acceptable contraceptive options.
A complimentary fact sheet provides additional information about Health Decisions’ capabilities for studies of contraceptives. For assistance with your contraceptive development program, please contact us.